Eupraxia Pharmaceuticals (EPRX) Current Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Current Assets of $136.8 million in Q2 2026, up 499.2% from $22.83 million a year earlier but down 3.7% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals reported Current Assets of $85.1 million, up 147.1% from FY2024.
- Annual Current Assets has increased for three straight years, with a three-year compound annual growth rate of 66.0% (FY2022 to FY2025).
- Across earlier years, Current Assets came in at $34.44 million in FY2024 (+73.9%), $19.8 million in FY2023 (+6.5%) and $18.59 million in FY2022.
- Quarterly Current Assets has ranged from $9.89 million in Q3 2024 to $142.13 million in Q1 2026 over the past five years.
- On a year-over-year basis, Current Assets has increased for four consecutive quarters, with growth averaging 273.3% over the last seven quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 824.2% in Q3 2025, against a decline of 21.0% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $142.13 million (Q1 2026), $85.1 million (Q4 2025) and $91.4 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 129.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 129.95 Mn |
| Jun 30, 2026 | 136.80 Mn |
| Mar 31, 2026 | 142.13 Mn |
| Dec 31, 2025 | 85.10 Mn |
| Sep 30, 2025 | 91.40 Mn |
| Jun 30, 2025 | 22.83 Mn |
| Mar 31, 2025 | 28.61 Mn |
| Dec 31, 2024 | 34.44 Mn |
| Sep 30, 2024 | 9.89 Mn |
| Jun 30, 2024 | 24.53 Mn |
| Mar 31, 2024 | 36.22 Mn |
| Dec 31, 2023 | 19.80 Mn |
| Dec 31, 2022 | 18.59 Mn |
API Access
Eupraxia Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();